Chael Sonnen is expected to face Mauricio Rua at UFC Fight Night 26, which takes place at TD Garden in Boston, Mass., on Aug. 17, 2013, headlining the first-ever fight card on Fox Sports 1. And he fully expects to be granted a therapeutic use exemption (TUE) for testosterone replacement therapy (TRT) if and when he is granted his license to compete in the state.
However, just two weeks out from fight night, Sonnen's situation remains unofficial despite his comments to the contrary.
Bleacher Report reached out to the Massachusetts State Athletic Commission to find out the status of Sonnen's license and application for a TUE. While Sonnen is confident that he'll be allowed to use TRT, the commission hasn't yet made a decision.
Here is the latest:
The Massachusetts State Athletic Commission has not issued a license to Chael Sonnen to participate in the August MMA event scheduled in Boston but has preliminarily agreed to allow him to fight. Sonnen, however, would be required to undergo testing to determine his testosterone levels both before and after the contest. TUE (therapeutic use exemption) for testosterone is uncharted territory for the Commission which has sent the issue to its Medical Advisory Board to determine allowable ratios prior to the fight and issuing Mr. Sonnen a fight license.
This wouldn't be the first time that Sonnen faced scrutiny for his TRT usage. His drug test following his UFC 117 bout with Anderson Silva showed elevated levels of testosterone, which were far outside the allowable limit. The urinalysis showed he had a 16.9:1 T:E ratio, almost 17 times that of a normal adult male. California allows for a 4:1 ratio.
He was suspended, but in his appeal to the state, we learned that his elevated levels were because of TRT, which he needed for hypogonadism. He was granted a TUE in Nevada, with a 6:1 allowable ratio, for his UFC 148 rematch against "The Spider."
Hopefully, this doesn't put the bout in jeopardy.